EPIX - ESSA Pharma Inc
ESSA Pharma Inc Logo

EPIX - ESSA Pharma Inc

https://www.essapharma.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

ESSA Pharma Inc., a clinical-stage pharmaceutical company, is focused on developing novel and proprietary therapies for the treatment of prostate cancer. The company is headquartered in Vancouver, Canada.

52W High
$7.88
52W Low
$0.22
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.55
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-8.09
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
0.10
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
5.64%
Institutions (25–75% balanced)
74.16%
Shares Outstanding
47,308,400
Float
33,355,700
Dividend Yield (2–6% sweet spot)
0.88%
Ex‑Dividend Date
2025-08-25
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-0.57
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.21%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.1163
Previous
-0.1186
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025